ZAI Lab Competitors and Similar CompaniesClear all

ZAI Lab's competitors and similar companies include Berry Genomics.
ZAI Lab
ZAI Lab
Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases.
Berry Genomics
Berry Genomics
Berry Genomics (贝瑞基因) is a biotechnology company that develops sequencing-based integrated solutions for life sciences and clinical applications, primarily in genetic testing and oncology testing.
Founding Date
Founding Date
2014
Founding Date
2010
Type
Type
Public
Type
Public
Tags
Locations
Locations
CN HQ
Suzhou, CN
Hong Kong, HK
Taipei, TW
Cambridge, US
Menlo Park, US
Locations
CN HQ
Employees
Employees
1,869
Employees
1,402
Valuation ($)
Valuation ($)
3.2 b
Valuation ($)
460.5 m

Financial

Revenue (est.)
Revenue (est.)
$460.2m (FY, 2025)
Revenue (est.)
¥1b (FY, 2024)
Cost of goods
Cost of goods
$190.5m (FY, 2025)
Cost of goods
¥572.9m (FY, 2024)
Gross profit
Gross profit
$269.6m (FY, 2025)
Gross profit
¥494m (FY, 2024)
Net income
Net income
($175.5m) (FY, 2025)
Net income
(¥188.2m) (FY, 2024)

Funding

Total funding raised
Total funding raised
$ 985m
Total funding raised
$ 145.7m
For sources of this data, please see the company profile

View Company Profiles

Berry Genomics
HQ
CN
Employees
1,402

Berry Genomics (贝瑞基因) is a biotechnology company that develops sequencing-based integrated solutions for life sciences and clinical applications, primarily in genetic testing and oncology testing.

View company